Global IVD (In Vitro Diagnostics) Products Market Outlook , 2030

2024

Global IVD (In Vitro Diagnostics) Products Market Outlook , 2030

Name: Global IVD (In Vitro Diagnostics) Products Market Outlook , 2030
Brand: Bonafide Research
SKU: 95001083
Price: 3450 USD
Availability: InStock
Rating: 5 (28.8 reviews)

The Global IVD Products Market is projected to exceed $134,810 billion by 2030, driven by strict global regulations on quality, safety, and performance to ensure diagnostic reliabi

Bonafide Trust
19-06-2024
Pages : 111
Figures : 81
Tables : 122
Region : Global
Category : Lifescience & Healthcare
Medical Devices

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global in vitro diagnostics (IVD) products market is a dynamic landscape driven by advancements in medical technology, increasing healthcare spending, and growing awareness of disease prevention and early diagnosis. IVD products play a crucial role in the healthcare ecosystem, providing essential tools for the diagnosis, monitoring, and treatment of various diseases. The market encompasses a wide range of products, from rapid diagnostic tests to sophisticated laboratory equipment, catering to the diverse needs of healthcare professionals and patients. The global IVD market exhibits significant regional variations, reflecting differences in healthcare infrastructure, disease prevalence, and regulatory frameworks. Developed economies, such as North America and Europe, have mature IVD markets characterized by advanced technology, stringent regulatory standards, and a focus on personalized medicine. These regions have witnessed substantial investments in research and development, leading to the introduction of innovative IVD products. In contrast, emerging markets in Asia-Pacific and Latin America are experiencing rapid growth in IVD demand due to increasing healthcare spending, rising awareness of preventive healthcare, and the expansion of diagnostic networks. However, these regions may face challenges in terms of infrastructure development, regulatory compliance, and access to advanced technologies. The MEA (Middle East and Africa) IVD market is a rapidly evolving landscape, driven by factors such as increasing population, urbanization, and rising healthcare expenditures. The region's growing focus on disease prevention and early diagnosis has created opportunities for IVD products. However, the market is characterized by varying levels of healthcare infrastructure development and regulatory frameworks across different countries.

According to the research report, “Global IVD (In Vitro Diagnostics) Products Market Outlook, 2030” published by Bonafide Research, the market is anticipated to cross USD 134810 Billion by 2030 increasing from US$ 79300 million in 2023. Regulatory authorities worldwide impose stringent quality, safety, and performance standards to ensure the reliability of IVD products. Compliance with these regulations can be complex and time-consuming, requiring significant investments in quality management systems and regulatory affairs. However, adherence to regulatory requirements is essential for market access and patient safety. Opportunities for growth in the global IVD market are driven by factors such as increasing disease prevalence, technological advancements, and rising healthcare expenditures. The growing focus on personalized medicine and early disease detection is creating demand for innovative IVD solutions. Additionally, the integration of IVD products with electronic health records (EHRs) and other digital health technologies is enhancing patient care and data management. Pricing in the IVD products market is influenced by factors such as product complexity, performance, and brand reputation. While some IVD products are relatively affordable, others, particularly those with advanced technologies, can be expensive. The average selling price (ASP) varies significantly across different product categories and market segments. The IVD market faces competition from substitute products, such as clinical laboratory tests and imaging techniques. However, IVD products often offer advantages in terms of speed, accuracy, and point-of-care testing capabilities. Effective marketing and promotion of IVD products are essential for building brand awareness, reaching target audiences, and driving sales. Industry events, trade shows, and conferences provide platforms for showcasing new products, networking with healthcare professionals, and staying abreast of market trends. The global economy, measured by purchasing power parity (PPP), influences the IVD market. Countries with higher per capita income generally have greater healthcare spending, leading to higher demand for diagnostic products. However, access to IVD products can be limited in lower-income countries due to affordability concerns. Population demographics, including age distribution, disease prevalence, and urbanization, also impact Market Dynamics. An aging population, for instance, increases the demand for diagnostic tests for chronic diseases.
Market Dynamics
Market Drivers
Increasing Prevalence of Chronic Diseases: The rising incidence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer, is a major driver for the IVD market. Early and accurate diagnosis of these conditions is crucial for effective management and treatment. The demand for diagnostic tests to monitor disease progression and treatment response is steadily increasing.
Aging Population: The global population is aging rapidly, leading to an increased prevalence of age-related diseases. This demographic shift is creating a growing demand for diagnostic tests to screen, diagnose, and monitor conditions such as Alzheimer's disease, osteoporosis, and cardiovascular diseases.
Government Initiatives and Healthcare Reforms: Governments worldwide are investing in healthcare infrastructure and implementing healthcare reforms to improve population health. This includes initiatives to promote preventive care, early disease detection, and patient-centered care. These factors are driving the adoption of IVD technologies and expanding the market.
Market Challenges
• Regulatory Hurdles and Market Access: The IVD industry faces complex regulatory landscapes with varying approval processes and reimbursement policies across different countries. Obtaining regulatory approvals for new products can be time-consuming and expensive. Additionally, securing reimbursement for diagnostic tests can be challenging, especially in cost-constrained healthcare systems.
•
• Price Pressure and Competition: The IVD market is characterized by intense competition among established players and emerging companies. Price pressures, driven by healthcare cost containment efforts, are impacting profitability. The need for continuous innovation and differentiation is crucial for maintaining a competitive edge.
•
• Data Privacy and Security: The increasing use of digital technologies in IVD has raised concerns about data privacy and security. Protecting patient data and ensuring the confidentiality of diagnostic information is essential for maintaining trust and compliance with regulations.
Market Trends
Decentralization and Point-of-Care Testing: The IVD market is witnessing a significant shift towards decentralized and point-of-care (POC) testing. This trend is driven by the need for rapid diagnosis, patient convenience, and efficient healthcare delivery. Advancements in miniaturization and diagnostic technologies are enabling the development of portable and user-friendly devices for various applications, from infectious disease testing to chronic disease management.
Precision Medicine and Personalized Diagnostics: The growing emphasis on personalized medicine is driving the demand for advanced IVD tests. These tests provide insights into individual patient characteristics, allowing for tailored treatment plans and improved patient outcomes. The integration of genomics, proteomics, and other omics technologies is enabling the development of diagnostic assays that can identify biomarkers associated with specific diseases and patient subgroups.
Digital Health and Data Analytics: The convergence of IVD with digital health technologies is creating new opportunities for data-driven diagnostics. The integration of connected devices, artificial intelligence, and big data analytics is enabling the development of intelligent diagnostic platforms. These platforms can enhance diagnostic accuracy, improve disease management, and facilitate remote patient monitoring.
•
Segmentation Analysis
Immunodiagnostics lead in the Global IVD (In Vitro Diagnostics) Products Market due to their wide range of applications, high sensitivity and specificity, and growing demand for personalized medicine.
Immunodiagnostics, a cornerstone of the IVD market, leverages the principles of immunology to detect and measure specific substances in biological samples. This segment encompasses a vast array of tests, including immunoassays, flow cytometry, and allergy testing, each with its unique applications in disease diagnosis, monitoring, and management. The widespread use of immunoassays, particularly enzyme-linked immunosorbent assays (ELISA), has solidified the segment's dominance. ELISA's versatility, coupled with its ability to detect a broad spectrum of analytes, has made it indispensable in clinical laboratories worldwide. Flow cytometry, another key component of immunodiagnostics, has revolutionized the analysis of cells and their characteristics. This technology allows for the simultaneous measurement of multiple parameters, enabling precise identification and quantification of different cell types. Its application extends beyond hematology to immunology, oncology, and infectious disease diagnostics. While flow cytometry is primarily used in centralized laboratories, the emergence of miniaturized flow cytometers is expanding its reach into POC settings. Allergy testing, a specialized area within immunodiagnostics, has grown significantly due to the rising prevalence of allergic diseases. Skin prick tests, radioallergosorbent tests (RAST), and component-resolved diagnostics (CRD) are commonly used to identify allergens and manage allergic conditions. The increasing awareness of allergic diseases and the availability of personalized treatment options have contributed to the growth of this subsegment.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Hospitals lead in the Global IVD (In Vitro Diagnostics) Products Market due to the high volume of diagnostic tests conducted for patient care, research, and disease screening.

Hospitals form the bedrock of the IVD market, serving as the primary consumers of diagnostic products and services. This segment is characterized by a complex interplay of factors, including patient volume, disease prevalence, technological advancements, and economic conditions. The role of hospitals as early adopters of innovative diagnostic technologies is paramount, driving the overall IVD market growth. The integration of IVD products into routine patient care pathways is a key driver for this segment. From initial screening and diagnosis to disease management and monitoring, hospitals rely on a diverse range of IVD tests to inform treatment decisions. The increasing prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and cancer, has led to a surge in demand for diagnostic tests to monitor disease progression and treatment efficacy. Moreover, the growing emphasis on preventive healthcare and early disease detection has expanded the utilization of IVD products in hospitals. The hospital laboratory, often the nerve center of diagnostic services, plays a pivotal role in the IVD market. These laboratories are equipped with advanced technologies and skilled personnel to perform a wide array of tests. The demand for accurate, rapid, and cost-effective diagnostics has driven the adoption of automated and standardized testing platforms. Additionally, the trend towards point-of-care testing (POCT) has gained traction in hospital settings, enabling faster diagnosis and improved patient outcomes. Beyond routine diagnostics, hospitals are increasingly adopting molecular diagnostics and advanced imaging techniques to address complex medical conditions. These technologies offer greater sensitivity and specificity, enabling earlier disease detection and personalized treatment plans. However, the implementation of such technologies requires significant investments in infrastructure, training, and quality control.

Regional Analysis
North America leads in the Flip Chip market due to healthcare infrastructure, strong Market Dynamics, and technological advancements.
North America currently holds the leading position in the global IVD market. This dominance is primarily attributed to a combination of factors. Firstly, the region boasts a highly developed healthcare infrastructure, with a strong network of hospitals, clinics, and diagnostic laboratories. This well-established infrastructure provides a solid foundation for the growth and adoption of IVD technologies. Secondly, North America has a large and diverse population with a high prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and cancer, which drive demand for diagnostic testing. Thirdly, the region is home to several leading IVD companies, many of which have a global presence and a strong research and development focus. These companies contribute to the market's growth through innovation, product launches, and partnerships. Finally, favorable government policies and reimbursement mechanisms in North America have created a conducive environment for the IVD industry, encouraging investment and market expansion. While other regions, such as Asia-Pacific, are experiencing rapid growth, North America's established healthcare infrastructure, strong Market Dynamics, and technological advancements solidify its position as the leading player in the global IVD market.
Key Developments
In Novermber 2023, Newland EMEA, a manufacturer of medical-grade tubing and profiles, announced the launch of its new in-vitro diagnostics (IVD) product line at Medica, a leading medical trade fair. This new product line is designed to meet the specific requirements of the IVD industry, offering high purity, biocompatibility, and regulatory compliance for critical diagnostic applications.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global IVD (In Vitro Diagnostics) Products Market Size 2019-2030
2.1.2 IVD (In Vitro Diagnostics) Products Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 IVD (In Vitro Diagnostics) Products Segment by Type
2.2.1 Immuno Diagnostics
2.2.2 Molecular Diagnostics
2.2.3 Tissue Diagnostics
2.2.4 Others
2.3 IVD (In Vitro Diagnostics) Products Market Size by Type
2.3.1 IVD (In Vitro Diagnostics) Products Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global IVD (In Vitro Diagnostics) Products Market Size Market Share by Type (2019-2024)
2.4 IVD (In Vitro Diagnostics) Products Segment by Application
2.4.1 Hospital
2.4.2 Laboratories
2.4.3 Research & Academic
2.4.4 Others
2.5 IVD (In Vitro Diagnostics) Products Market Size by Application
2.5.1 IVD (In Vitro Diagnostics) Products Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global IVD (In Vitro Diagnostics) Products Market Size Market Share by Application (2019-2024)
3 IVD (In Vitro Diagnostics) Products Market Size by Player
3.1 IVD (In Vitro Diagnostics) Products Market Size Market Share by Players
3.1.1 Global IVD (In Vitro Diagnostics) Products Revenue by Players (2019-2024)
3.1.2 Global IVD (In Vitro Diagnostics) Products Revenue Market Share by Players (2019-2024)
3.2 Global IVD (In Vitro Diagnostics) Products Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IVD (In Vitro Diagnostics) Products by Regions
4.1 IVD (In Vitro Diagnostics) Products Market Size by Regions (2019-2024)
4.2 Americas IVD (In Vitro Diagnostics) Products Market Size Growth (2019-2024)
4.3 APAC IVD (In Vitro Diagnostics) Products Market Size Growth (2019-2024)
4.4 Europe IVD (In Vitro Diagnostics) Products Market Size Growth (2019-2024)
4.5 Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size Growth (2019-2024)
5 Americas
5.1 Americas IVD (In Vitro Diagnostics) Products Market Size by Country (2019-2024)
5.2 Americas IVD (In Vitro Diagnostics) Products Market Size by Type (2019-2024)
5.3 Americas IVD (In Vitro Diagnostics) Products Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IVD (In Vitro Diagnostics) Products Market Size by Region (2019-2024)
6.2 APAC IVD (In Vitro Diagnostics) Products Market Size by Type (2019-2024)
6.3 APAC IVD (In Vitro Diagnostics) Products Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe IVD (In Vitro Diagnostics) Products by Country (2019-2024)
7.2 Europe IVD (In Vitro Diagnostics) Products Market Size by Type (2019-2024)
7.3 Europe IVD (In Vitro Diagnostics) Products Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa IVD (In Vitro Diagnostics) Products by Region (2019-2024)
8.2 Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size by Type (2019-2024)
8.3 Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global IVD (In Vitro Diagnostics) Products Market Forecast
10.1 Global IVD (In Vitro Diagnostics) Products Forecast by Regions (2025-2030)
10.1.1 Global IVD (In Vitro Diagnostics) Products Forecast by Regions (2025-2030)
10.1.2 Americas IVD (In Vitro Diagnostics) Products Forecast
10.1.3 APAC IVD (In Vitro Diagnostics) Products Forecast
10.1.4 Europe IVD (In Vitro Diagnostics) Products Forecast
10.1.5 Middle East & Africa IVD (In Vitro Diagnostics) Products Forecast
10.2 Americas IVD (In Vitro Diagnostics) Products Forecast by Country (2025-2030)
10.2.1 United States IVD (In Vitro Diagnostics) Products Market Forecast
10.2.2 Canada IVD (In Vitro Diagnostics) Products Market Forecast
10.2.3 Mexico IVD (In Vitro Diagnostics) Products Market Forecast
10.2.4 Brazil IVD (In Vitro Diagnostics) Products Market Forecast
10.3 APAC IVD (In Vitro Diagnostics) Products Forecast by Region (2025-2030)
10.3.1 China IVD (In Vitro Diagnostics) Products Market Forecast
10.3.2 Japan IVD (In Vitro Diagnostics) Products Market Forecast
10.3.3 Korea IVD (In Vitro Diagnostics) Products Market Forecast
10.3.4 Southeast Asia IVD (In Vitro Diagnostics) Products Market Forecast
10.3.5 India IVD (In Vitro Diagnostics) Products Market Forecast
10.3.6 Australia IVD (In Vitro Diagnostics) Products Market Forecast
10.4 Europe IVD (In Vitro Diagnostics) Products Forecast by Country (2025-2030)
10.4.1 Germany IVD (In Vitro Diagnostics) Products Market Forecast
10.4.2 France IVD (In Vitro Diagnostics) Products Market Forecast
10.4.3 UK IVD (In Vitro Diagnostics) Products Market Forecast
10.4.4 Italy IVD (In Vitro Diagnostics) Products Market Forecast
10.4.5 Russia IVD (In Vitro Diagnostics) Products Market Forecast
10.5 Middle East & Africa IVD (In Vitro Diagnostics) Products Forecast by Region (2025-2030)
10.5.1 Egypt IVD (In Vitro Diagnostics) Products Market Forecast
10.5.2 South Africa IVD (In Vitro Diagnostics) Products Market Forecast
10.5.3 Israel IVD (In Vitro Diagnostics) Products Market Forecast
10.5.4 Turkey IVD (In Vitro Diagnostics) Products Market Forecast
10.5.5 GCC Countries IVD (In Vitro Diagnostics) Products Market Forecast
10.6 Global IVD (In Vitro Diagnostics) Products Forecast by Type (2025-2030)
10.7 Global IVD (In Vitro Diagnostics) Products Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific IVD (In Vitro Diagnostics) Products Product Offered
11.1.3 Thermo Fisher Scientific IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Information
11.2.2 Roche Diagnostics IVD (In Vitro Diagnostics) Products Product Offered
11.2.3 Roche Diagnostics IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Diagnostics Main Business Overview
11.2.5 Roche Diagnostics Latest Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Information
11.3.2 Abbott Laboratories IVD (In Vitro Diagnostics) Products Product Offered
11.3.3 Abbott Laboratories IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abbott Laboratories Main Business Overview
11.3.5 Abbott Laboratories Latest Developments
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Information
11.4.2 Becton Dickinson IVD (In Vitro Diagnostics) Products Product Offered
11.4.3 Becton Dickinson IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Becton Dickinson Main Business Overview
11.4.5 Becton Dickinson Latest Developments
11.5 BioMérieuxSA
11.5.1 BioMérieuxSA Company Information
11.5.2 BioMérieuxSA IVD (In Vitro Diagnostics) Products Product Offered
11.5.3 BioMérieuxSA IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BioMérieuxSA Main Business Overview
11.5.5 BioMérieuxSA Latest Developments
11.6 Immucor
11.6.1 Immucor Company Information
11.6.2 Immucor IVD (In Vitro Diagnostics) Products Product Offered
11.6.3 Immucor IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Immucor Main Business Overview
11.6.5 Immucor Latest Developments
11.7 Illumina
11.7.1 Illumina Company Information
11.7.2 Illumina IVD (In Vitro Diagnostics) Products Product Offered
11.7.3 Illumina IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Illumina Main Business Overview
11.7.5 Illumina Latest Developments
11.8 Luminex Corporation
11.8.1 Luminex Corporation Company Information
11.8.2 Luminex Corporation IVD (In Vitro Diagnostics) Products Product Offered
11.8.3 Luminex Corporation IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Luminex Corporation Main Business Overview
11.8.5 Luminex Corporation Latest Developments
11.9 CareDx
11.9.1 CareDx Company Information
11.9.2 CareDx IVD (In Vitro Diagnostics) Products Product Offered
11.9.3 CareDx IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 CareDx Main Business Overview
11.9.5 CareDx Latest Developments
11.10 Hologic
11.10.1 Hologic Company Information
11.10.2 Hologic IVD (In Vitro Diagnostics) Products Product Offered
11.10.3 Hologic IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Hologic Main Business Overview
11.10.5 Hologic Latest Developments
11.11 GenDx
11.11.1 GenDx Company Information
11.11.2 GenDx IVD (In Vitro Diagnostics) Products Product Offered
11.11.3 GenDx IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 GenDx Main Business Overview
11.11.5 GenDx Latest Developments
11.12 Biofortuna
11.12.1 Biofortuna Company Information
11.12.2 Biofortuna IVD (In Vitro Diagnostics) Products Product Offered
11.12.3 Biofortuna IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Biofortuna Main Business Overview
11.12.5 Biofortuna Latest Developments
11.13 QIAGEN NV
11.13.1 QIAGEN NV Company Information
11.13.2 QIAGEN NV IVD (In Vitro Diagnostics) Products Product Offered
11.13.3 QIAGEN NV IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 QIAGEN NV Main Business Overview
11.13.5 QIAGEN NV Latest Developments
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Information
11.14.2 Bio-Rad Laboratories IVD (In Vitro Diagnostics) Products Product Offered
11.14.3 Bio-Rad Laboratories IVD (In Vitro Diagnostics) Products Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Bio-Rad Laboratories Main Business Overview
11.14.5 Bio-Rad Laboratories Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. IVD (In Vitro Diagnostics) Products Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Immuno Diagnostics
Table 3. Major Players of Molecular Diagnostics
Table 4. Major Players of Tissue Diagnostics
Table 5. Major Players of Others
Table 6. IVD (In Vitro Diagnostics) Products Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global IVD (In Vitro Diagnostics) Products Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global IVD (In Vitro Diagnostics) Products Market Size Market Share by Type (2019-2024)
Table 9. IVD (In Vitro Diagnostics) Products Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global IVD (In Vitro Diagnostics) Products Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global IVD (In Vitro Diagnostics) Products Market Size Market Share by Application (2019-2024)
Table 12. Global IVD (In Vitro Diagnostics) Products Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global IVD (In Vitro Diagnostics) Products Revenue Market Share by Player (2019-2024)
Table 14. IVD (In Vitro Diagnostics) Products Key Players Head office and Products Offered
Table 15. IVD (In Vitro Diagnostics) Products Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global IVD (In Vitro Diagnostics) Products Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global IVD (In Vitro Diagnostics) Products Market Size Market Share by Regions (2019-2024)
Table 20. Global IVD (In Vitro Diagnostics) Products Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global IVD (In Vitro Diagnostics) Products Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas IVD (In Vitro Diagnostics) Products Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas IVD (In Vitro Diagnostics) Products Market Size Market Share by Country (2019-2024)
Table 24. Americas IVD (In Vitro Diagnostics) Products Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas IVD (In Vitro Diagnostics) Products Market Size Market Share by Type (2019-2024)
Table 26. Americas IVD (In Vitro Diagnostics) Products Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas IVD (In Vitro Diagnostics) Products Market Size Market Share by Application (2019-2024)
Table 28. APAC IVD (In Vitro Diagnostics) Products Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC IVD (In Vitro Diagnostics) Products Market Size Market Share by Region (2019-2024)
Table 30. APAC IVD (In Vitro Diagnostics) Products Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC IVD (In Vitro Diagnostics) Products Market Size Market Share by Type (2019-2024)
Table 32. APAC IVD (In Vitro Diagnostics) Products Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC IVD (In Vitro Diagnostics) Products Market Size Market Share by Application (2019-2024)
Table 34. Europe IVD (In Vitro Diagnostics) Products Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe IVD (In Vitro Diagnostics) Products Market Size Market Share by Country (2019-2024)
Table 36. Europe IVD (In Vitro Diagnostics) Products Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe IVD (In Vitro Diagnostics) Products Market Size Market Share by Type (2019-2024)
Table 38. Europe IVD (In Vitro Diagnostics) Products Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe IVD (In Vitro Diagnostics) Products Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of IVD (In Vitro Diagnostics) Products
Table 47. Key Market Challenges & Risks of IVD (In Vitro Diagnostics) Products
Table 48. Key Industry Trends of IVD (In Vitro Diagnostics) Products
Table 49. Global IVD (In Vitro Diagnostics) Products Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global IVD (In Vitro Diagnostics) Products Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global IVD (In Vitro Diagnostics) Products Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global IVD (In Vitro Diagnostics) Products Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Thermo Fisher Scientific Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 54. Thermo Fisher Scientific IVD (In Vitro Diagnostics) Products Product Offered
Table 55. Thermo Fisher Scientific IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Thermo Fisher Scientific Main Business
Table 57. Thermo Fisher Scientific Latest Developments
Table 58. Roche Diagnostics Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 59. Roche Diagnostics IVD (In Vitro Diagnostics) Products Product Offered
Table 60. Roche Diagnostics Main Business
Table 61. Roche Diagnostics IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Diagnostics Latest Developments
Table 63. Abbott Laboratories Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 64. Abbott Laboratories IVD (In Vitro Diagnostics) Products Product Offered
Table 65. Abbott Laboratories Main Business
Table 66. Abbott Laboratories IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Abbott Laboratories Latest Developments
Table 68. Becton Dickinson Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 69. Becton Dickinson IVD (In Vitro Diagnostics) Products Product Offered
Table 70. Becton Dickinson Main Business
Table 71. Becton Dickinson IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Becton Dickinson Latest Developments
Table 73. BioMérieuxSA Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 74. BioMérieuxSA IVD (In Vitro Diagnostics) Products Product Offered
Table 75. BioMérieuxSA Main Business
Table 76. BioMérieuxSA IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. BioMérieuxSA Latest Developments
Table 78. Immucor Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 79. Immucor IVD (In Vitro Diagnostics) Products Product Offered
Table 80. Immucor Main Business
Table 81. Immucor IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Immucor Latest Developments
Table 83. Illumina Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 84. Illumina IVD (In Vitro Diagnostics) Products Product Offered
Table 85. Illumina Main Business
Table 86. Illumina IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Illumina Latest Developments
Table 88. Luminex Corporation Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 89. Luminex Corporation IVD (In Vitro Diagnostics) Products Product Offered
Table 90. Luminex Corporation Main Business
Table 91. Luminex Corporation IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Luminex Corporation Latest Developments
Table 93. CareDx Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 94. CareDx IVD (In Vitro Diagnostics) Products Product Offered
Table 95. CareDx Main Business
Table 96. CareDx IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. CareDx Latest Developments
Table 98. Hologic Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 99. Hologic IVD (In Vitro Diagnostics) Products Product Offered
Table 100. Hologic Main Business
Table 101. Hologic IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Hologic Latest Developments
Table 103. GenDx Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 104. GenDx IVD (In Vitro Diagnostics) Products Product Offered
Table 105. GenDx IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. GenDx Main Business
Table 107. GenDx Latest Developments
Table 108. Biofortuna Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 109. Biofortuna IVD (In Vitro Diagnostics) Products Product Offered
Table 110. Biofortuna Main Business
Table 111. Biofortuna IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Biofortuna Latest Developments
Table 113. QIAGEN NV Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 114. QIAGEN NV IVD (In Vitro Diagnostics) Products Product Offered
Table 115. QIAGEN NV Main Business
Table 116. QIAGEN NV IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. QIAGEN NV Latest Developments
Table 118. Bio-Rad Laboratories Details, Company Type, IVD (In Vitro Diagnostics) Products Area Served and Its Competitors
Table 119. Bio-Rad Laboratories IVD (In Vitro Diagnostics) Products Product Offered
Table 120. Bio-Rad Laboratories Main Business
Table 121. Bio-Rad Laboratories IVD (In Vitro Diagnostics) Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Bio-Rad Laboratories Latest Developments

List of Figures
Figure 1. IVD (In Vitro Diagnostics) Products Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global IVD (In Vitro Diagnostics) Products Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. IVD (In Vitro Diagnostics) Products Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. IVD (In Vitro Diagnostics) Products Sales Market Share by Country/Region (2023)
Figure 8. IVD (In Vitro Diagnostics) Products Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global IVD (In Vitro Diagnostics) Products Market Size Market Share by Type in 2023
Figure 10. IVD (In Vitro Diagnostics) Products in Hospital
Figure 11. Global IVD (In Vitro Diagnostics) Products Market: Hospital (2019-2024) & ($ Millions)
Figure 12. IVD (In Vitro Diagnostics) Products in Laboratories
Figure 13. Global IVD (In Vitro Diagnostics) Products Market: Laboratories (2019-2024) & ($ Millions)
Figure 14. IVD (In Vitro Diagnostics) Products in Research & Academic
Figure 15. Global IVD (In Vitro Diagnostics) Products Market: Research & Academic (2019-2024) & ($ Millions)
Figure 16. IVD (In Vitro Diagnostics) Products in Others
Figure 17. Global IVD (In Vitro Diagnostics) Products Market: Others (2019-2024) & ($ Millions)
Figure 18. Global IVD (In Vitro Diagnostics) Products Market Size Market Share by Application in 2023
Figure 19. Global IVD (In Vitro Diagnostics) Products Revenue Market Share by Player in 2023
Figure 20. Global IVD (In Vitro Diagnostics) Products Market Size Market Share by Regions (2019-2024)
Figure 21. Americas IVD (In Vitro Diagnostics) Products Market Size 2019-2024 ($ Millions)
Figure 22. APAC IVD (In Vitro Diagnostics) Products Market Size 2019-2024 ($ Millions)
Figure 23. Europe IVD (In Vitro Diagnostics) Products Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size 2019-2024 ($ Millions)
Figure 25. Americas IVD (In Vitro Diagnostics) Products Value Market Share by Country in 2023
Figure 26. United States IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC IVD (In Vitro Diagnostics) Products Market Size Market Share by Region in 2023
Figure 31. APAC IVD (In Vitro Diagnostics) Products Market Size Market Share by Type in 2023
Figure 32. APAC IVD (In Vitro Diagnostics) Products Market Size Market Share by Application in 2023
Figure 33. China IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 37. India IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe IVD (In Vitro Diagnostics) Products Market Size Market Share by Country in 2023
Figure 40. Europe IVD (In Vitro Diagnostics) Products Market Size Market Share by Type (2019-2024)
Figure 41. Europe IVD (In Vitro Diagnostics) Products Market Size Market Share by Application (2019-2024)
Figure 42. Germany IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 43. France IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size Market Share by Application (2019-2024)
Figure 50. Egypt IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country IVD (In Vitro Diagnostics) Products Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 56. APAC IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 57. Europe IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 59. United States IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 60. Canada IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 61. Mexico IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 62. Brazil IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 63. China IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 64. Japan IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 65. Korea IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 67. India IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 68. Australia IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 69. Germany IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 70. France IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 71. UK IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 72. Italy IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 73. Russia IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 74. Spain IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 75. Egypt IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 76. South Africa IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 77. Israel IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 78. Turkey IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries IVD (In Vitro Diagnostics) Products Market Size 2025-2030 ($ Millions)
Figure 80. Global IVD (In Vitro Diagnostics) Products Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global IVD (In Vitro Diagnostics) Products Market Size Market Share Forecast by Application (2025-2030)
"

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted